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Tight junctions are dynamic cellular structures that are critical for compartmentalizing 
the apical and basal environments within tissues and regulating transport of small molecules, 
ions, and fluids. There are a plethora of protein families that comprise the tight junction (i.e. the 
three ZO families, over 24 claudin families, the MARVEL family, JAM family, etc) that are 
responsible for maintaining tight junction integrity. Studies have demonstrated that ZO-1, one of 
the tight junction proteins, is an organizer of tight junctions and claudins, another tight junction 
protein, contribute a critical role in establishing the barrier properties of the tight junction. 
However, recent studies have shown that occludin, a transmembrane protein, may also have 
regulatory functions in maintaining the tight junction. One of these functions is the 
phosphorylation-dependent binding of occludin to the protein ZO-1. Ser471, a phosphosite, is 
within a negatively charged region of the coiled-coil domain of occludin and interacts with ZO-
1. Ongoing studies expressing phosphoinhibitory mutations of Ser471 (i.e. Ser471A) 
demonstrated that these mutants act in a dominant fashion to prevent proper tight junction 
formation and induce dramatic increase in solute permeability and ion flux. Previous studies 
have also demonstrated other mutants of occludin that may provide an ion specific alteration in 
permeability.  
In this study, we tested the hypothesis that expression of Ser471A induces a non-selective 
ion flux due to observed gaps in tight junctions of Ser471A MDCK cells. To quantify the ion 
flux, experiments were performed using MDCK cell lines that expressed WTOcc, Ser471A, and 
Ser471D (n = 12) in an Ussing chamber and calculated, using the Goldman-Hodgkin-Katz and 
Kimizuka-Koketsu equations, the absolute permeability of sodium, potassium, and chloride ions. 
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We hypothesized that the malformed tight junctions in the Ser471A cell line will cause non-
selective ion flux (i.e. an increase in absolute permeability for all three ions).  
After measuring the permeability values for sodium, potassium, and chloride ions, we 
found that all three permeability values significantly increased in the Ser471A cell line compared 
to parental, WTOcc, and Ser471D (P <0.05) suggesting non-specific ion flux. This study is 
consistent with ongoing research in the laboratory demonstrating that phosphorylation of Ser471 
contributes to epithelial cell packing and proper tight junction formation. 
Possible limitations of this project is that liquid junction potential was not taken into 
consideration and more cations and anions need to be tested. To further validate our findings, we 
will repeat the above protocol with the corrected equation to eliminate the liquid junction 
potential error and more ions to further justify the non-selective ion permeability in the Ser471A 















Multicellular organisms require tissue barriers to help create and maintain defined 
environments. How these barriers are created and maintained remain an area of active research. 
Cells interact with one another through direct cell-cell junctions, or they may be bound together 
by extracellular materials that they secrete (Alberts et al., 2008). In either scenario, the formation 
of these interactions is imperative in order for cells to form tissues (i.e. epithelial, connective, 
muscle, nervous, and blood) and other larger structures (i.e. heart, brain, liver, lung, kidney, etc.).  
There are two main ways animal cells are bound together: cell-cell adhesion and cell-
matrix adhesion (Alberts et al., 2008).  In connective tissue, the main stress-bearing component 
is the extracellular matrix and as a result the matrix bears mechanical stresses of tension and 
compression. In epithelial tissue, it is the cytoskeletons of the cells themselves, linked from cell 
to cell by anchoring junctions. The cell-matrix attachments bind epithelial tissue to the 
connective tissue below it and the cell-cell adhesion sites connect adjacent cells to one another. 
These cell adhesions are important because they can handle mechanical stresses, provide barriers 
between the extracellular and intracellular environment of an organism, organize directions of 
cell growth, and create blood tissue barriers. 
Though binding cells to their environment is important (i.e. physical attachment) for both 
epithelia and in non-epithelial tissues, junctions between cell and cell or between cell and matrix 
are diverse in structure and have several other functions. There are four functional classes of cell 
junctions in animal tissues: anchoring junctions, channel-forming junctions, signal-relaying 





There are four types of anchoring junctions: adherens junction, desmosome, actin-inked 
cell-matrix adhesion, and hemidesmosome. The former two are involved in cell-cell junctions 
and the latter two are involved in cell-matrix junctions. Transmembrane adhesion proteins play 
the central role for each of these anchoring junctions. These proteins span the membrane, with 
one end linked to the intracellular cytoskeleton and the other end linked to other extracellular 
structures. There are two superfamilies that these cytoskeleton-linked transmembrane fall into: 
cadherin and integrin. The former primarily mediates attachment of cell-to-cell, while the latter 
primarily mediates cell-to-matrix attachments. Each family is further classified based on their 
cellular connections (i.e. cadherins linked to actin form adherens junctions, while cadherins 
linked to intermediate filaments form desmosome junctions; integrins linked to actin form actin-
linked cell-matrix adhesions, while integrins linked intermediate filaments form 
hemidesmosomes) (Alberts et al., 2008).  
Adherens junctions connect actin filament bundles in one cell with that in the next cell. 
The transmembrane adhesion protein is known as E-cadherin for its presence in epithelial cells. 
These proteins make homophilic binding interactions with other cadherins on an adjacent cell. 
They bind with relatively low affinity, however, strong attachments result from the formation of 
many such weak bonds in parallel. The interaction among cadherins is analogous to that of a 
Velcro. Cadherins take their name from their dependence on Ca2+ ions. Studies have shown that 
adding Ca2+ ions to the extracellular medium causes adhesions mediated by cadherins to 
strengthen in mouse embryonic development (Alberts et al., 2008). These ions bind in the hinge 
regions in between adjacent cadherin domains. When Ca2+ is absent from the extracellular media, 
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the cadherins become flexible and the adhesion fails to form. In adherens junctions, cadherins are 
coupled indirectly to actin filaments via β-catenin, α-catenin, vinculin, and other anchor proteins. 
These junctions form a continuous adhesion belt near the apical surface of epithelial cells, 
encircling the interacting cells. The adhesion belt is tethered to actin filaments of the apical 
actomyosin belt. By indirectly linking actin filaments in one cell to those in its neighbors, 
adherens junctions coordinate the actomyosin-based forces among adjacent cells. The role of 
adherens junction interaction is to respond to increased cellular tension by strengthening their 
actin linkages.  The importance of adherens junctions and their components is perhaps best 
understood by their role in human diseases. The cadherin–catenin complex directly contributes to 
cancer initiation and progression. Loss of E-cadherin and α-catenin in cancer cells results in loss 
of adhesion and promotes proliferation and invasion. Somatic mutations in E-cadherin in 
combination with a loss of heterozygosity are observed in a range of human carcinomas and 
occur early during tumorigenesis (Berx et al., 1998). A role for E-cadherin as a tumor suppressor 
is further suggested by the finding of germline mutations in diffuse gastric cancer and lobular 
breast cancer. Mutations in β-catenin have been observed in colon carcinoma, pilomatricoma and 
melanoma but these do not directly affect adherens junctions. Instead these mutations cause an 
increase in Wnt signaling, which directly affects the adherens junctions (Alberts et al., 2008). 
Mutations in P-cadherin are found in hypotrichosis with juvenile macular dystrophy, a 
syndrome characterized by sparse and short hair and macular degeneration as well as a related 
ectodermal dysplasia syndrome called EEM (ectodermal dysplasia, ectrodactyly, macular 
dystrophy). Interestingly, nectin-1 mutations are found in another ectodermal dysplasia 
syndrome associated with cleft lip and palate. The p120 members ARVCF and δ-catenin are 
mutated in a human syndrome associated with craniofacial with mental retardation and in Cri-du-
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Chat syndrome associated with mental retardation, respectively. Overall, these mutations 
compromise the physiological function of adherens junctions (Lai-Cheong et al., 2007). 
Desmosomes are another form of anchoring junction that connects intermediate filaments 
in one cell to those in the next cell. The transmembrane adhesion proteins are desmosomal 
cadherins (i.e. desmoglein and desmocolin). Desmosomes are structurally similar to adherens 
junctions, except the latter link to intermediate filaments instead of actin. The major function of 
desmosomes is to provide mechanical strength. To form this junction, plakoglobin and 
plakophilin bind to cytoplasmic tail of desmoglein and desmocolin and bind to desmoplakin, 
which in turn binds to intermediate filaments. When adjacent cells are indirectly connected to 
one another through this intermediate filament network, the junction is known as a desmosome. 
Disruption of the desmosomes can result in the detachment of the epithelial from the basal layer. 
An example of such a clinical manifestation is epidermis bullosa, which is skin blistering 
resulting from mutant keratin genes (i.e. disrupted desmosome) that leads to rupturing of cells in 
the basal layer of the epidermis (Alberts et al., 2008).  
 On the other hand, if the intermediate filament network is attached to the cell on one side 
and the basal lamina on the other, the junction is called hemidesmosomes. An example of a 
clinical disorder involving hemidesmosomes is bullous pemphigoid. This disorder is an acute or 
chronic autoimmune skin disease, involving the formation of blisters at the space between the 
skin layers of epidermis and dermis caused by the body forming anti-hemidesmosome antibodies 
(Wolff et al., 2007). This autoimmune disorder is acquired mainly through exposure to 






 Gap junctions or channel-forming junctions are present in most animal tissues, including 
connective tissues as well as epithelia, allowing the cells to communicate with other adjacent 
cells. This junction allows the cytoplasmic content of one cell to form a direct passageway to the 
cytoplasmic content of another cell. The combinations of connexins that comprise gap junctions 
determine the properties of the junctions. Connexins are four-pass transmembrane proteins, six 
of which assemble to form a hemichannel, or a connexon. When the connexons in the plasma 
membranes of two cells come in contact and are aligned, they form a continuous aqueous 
channel that connect the two cell interiors (Alberts et al., 2008). These intercellular channels can 
be homotypic or heterotypic depending on the type of connexons that come together. Functions 
of these channels are diverse. A classic example is the gap junctions present in the heart to cause 
synchronous muscle contraction to maintain a heartbeat. Also, the cell can dynamically control 
these gap junctions. For instance, cytosolic pH changes can cause the channel to open or close to 
maintain physiological conditions by changing the permeability of various ions (Alberts et al., 
2008). In addition, gap junctions relay cell death signals from one apoptotic cell to the 
neighboring cell. This can cause otherwise unaffected, healthy adjacent cells to also go through 
apoptosis. This phenomenon is known as the bystander effect because of its ability of killing 








Anchoring, occluding, and channel-forming junctions all are capable of having signaling 
functions in addition to their structural roles. Examples of signal-relaying junctions include 
chemical synapses in the nervous system and immunological synapses in the immune system. 
Also the classic transmembrane ligand-receptor cell-cell signaling contacts (e.g. Delta-Notch, 
ephrin-Eph, etc.) are another form of signal-relaying junction (Alberts et al., 2008). An example 
of signal-relaying junction is the chemical synapse in the nervous system. In this junction an 
electrical impulse from neurons triggers the release of neurotransmitters in the synaptic cleft. 
Disruption of this system can lead to various disorders (i.e. myasthenia gravis and Lambert-




 The epithelial cells are attached to one side known as the basal side and free of any 
anchorage on their opposite side – the apical side (Farquhar and Palade, 1963; Claude and 
Goodenough, 1973). One function of all epithelia is to serve as a selective, permeable barrier - 
separating the fluid on the apical and basal side from mixing with one another. There are more 
specialized functions of epithelia depending on their location in the body. For example, kidney 
epithelia allow filtration of blood and reuptake of essential blood borne material. In order to 
fulfill this function, adjacent kidney epithelial cells are sealed together by occluding junctions to 
prevent apical content from mixing with that of the basal.  
 9 
 Likewise, occluding junctions in vertebral, epithelial small intestine cells fulfill a similar 
role. The small intestine is comprised of simple columnar epithelia (Alberts et al., 2008) that are 
responsible for the uptake of nutrients from the lumen of the gut and transport of these nutrients 
to the blood vessel. There are channels and proteins that are directed to the apical side of the 
epithelium and proteins directed to the basal side. The localization of proteins is imperative to 
maintain function of the small intestine. For example, the sodium-driven glucose symporter must 
be directed to the apical side so that glucose can diffuse from one side of the gradient to the 
other. Therefore, some structure in the cell must play an important role in maintaining proper 
localization of these channel proteins to their correct positions (i.e. apical or basal). It has been 
shown that tight junctions between epithelial cells may function to help separate domains within 
the plasma membrane to prevent drifting of the protein to the wrong side of the membrane 
(Alberts et al., 2008). In addition, tight junctions also facilitate the maintenance of a 
concentration gradient (i.e. prevent apical content from mixing with the basal content) by 
occluding adjacent epithelial cells in the most apical position. Through this function, tight 
junctions ensure the active transport of glucose from the lumen of the gut to the blood to nourish 
our body (i.e. transcellular transport) by preventing the apical content and basal content from 
mixing as well as directing channel proteins to their appropriate location in the cell.  
In order to function, tight junctions are comprised of multiple proteins known as tight 
junction proteins. The first tight junction protein identified was the scaffolding protein known as 
the zonula occludens (i.e. ZO proteins) (Stevenson et al., 1986). There are three classes of ZO: 
ZO-1, ZO-2, and ZO-3. The scaffolding proteins ZO-1, ZO-2, and ZO-3 play a unique role in the 
organization and regulation of tight junctions. These proteins are members of a family of 
membrane associated signaling proteins known as the membrane-associated guanylate kinase 
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homologs (MAGUKs) (Woods et al, 1993). Members of this family are distinguished by a core 
cassette of protein-binding domains, which include one or more PSD95/ dlg/ZO-1 (PDZ) 
domains, an SH3 domain, and a region of homology to guanylate kinase (GuK) (Fanning et al., 
1998). The function of the ZO proteins is to mediate binding to transmembrane tight junction 
proteins (Beatch et al., 1996; Stevenson et al., 1986) to form the diffusion barrier to separate the 






In a freeze fracture electron microscopy, the tight junctions appear as a network of 
sealing strands that encircle each cell on the apical side in the epithelial sheet (Staehelin, 1974). 
In conventional electron microscopy, the two plasma membranes interacting appear to be tightly 
apposed where sealing strands are present. In addition to these observational conclusions from 
microscopy, it was identified that each tight junction sealing-strand is made up of a long row of 
transmembrane adhesion proteins (Alberts et al., 2008) besides the ZO proteins.  
One of these proteins in the tight junction sealing strand is occludin, which is a tetrapass 
transmembrane protein that is ~65 kDa (Schneeberger and Lynch, 2004). Occludin – from the 
Latin word meaning ‘to block’ – was named because, at the time of its discovery, it was the only 
protein discovered in the most apical cellular region and was thought to play the main role in 
occluding paracellular flux (Furuse et al., 1993). Occludin has a long COOH-terminal 
cytoplasmic domain, a short NH2-terminal cytoplasmic domain, two extracellular loops, and one 
Figure 1. Domain Organization of the ZO-1 protein. These proteins are sub-families of MAGUK 
scaffolds and are known to function as structural organizer of the tight junction (Zhu et al., 2011). 
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intracellular turn. One of the most distinguishing features of its sequence is the high content of 





The function of occludin was partially identified by occluding gene deletion in in mice 
(Saitu et al., 2000). Through this molecular technique, the phenotype of the mice altered 
considerably when compared to wild type mice. For example, all occludin knockout mice had 
Figure 2. Diagram of Occludin Domains. Occludin is a tetraspan protein. The first extracellular 
loop of occludin is rich in tyrosine and glycine residues, and neither loop has a significant number 
of charged amino acid residues (image courtesy of Dr. David A. Antonetti). 
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postnatal growth retardation, the occludin knockout male mice produced no offspring when 
mated with either wild type or occludin knockdown females, the occludin knockout females did 
not exhibit proper weaning behavior after giving birth, and thinning of the compact bone in both 
genders were observed (Saitou et al., 2000).  One explanation of this result is that tight junctions 
exist in gastrointestinal epithelium and lack of occludin may affect Ca2+ uptake through the 
paracellular pathway. Likewise in mice, there are tight junctions in the Sertoli cells that may 
cause improper spermatogenesis causing sterility (Saitou et al., 2000). Even though multiple 
pathological events were noted in these knock out mice, the tight junction barrier did not change 
electrophysiologically. This outcome suggested that occludin is not the protein responsible for 
occluding paracellular flux, contrary to its name, and that another protein is responsible for this 
occlusion (Furuse et al., 1998). However, the multiple phenotypical changes suggested important 
roles in tissues regarding tight junctions. For example, the use of siRNA directed to occludin 
resulted in a selective increase in paracellular permeability of small organic cations (Yu et al., 
2005). 
However prior to that study, further validation that occludin was not the protein 
responsible for barrier formation was obtained when a mutated occludin, one that was COOH-
terminally truncated, was stably transfected into MDCK cells. This mutation did not affect the 
continuous network of tight junction strands (Balda et al., 1996). It was also shown that 
disruption of occludin genes in embryonic stem cells still led to the differentiation into epithelial 
cells with well-developed tight junctions (Furuse et al., 1998). These data confirm that there 
exists another protein that is also responsible for maintaining the tight junction integrity in 
addition to occludin and ZO. Claudins – named for the Latin word ‘claudere’ meaning to close – 
is the most essential protein for tight junction formation and function (Umeda et al., 2006). 
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Claudins are tetrapass transmembrane proteins that have no sequence homology to occludins 
(Furuse et al., 1998). There are twenty-four claudin family members differentially expressed in 
different tissues and the amino acid composition of the two extracellular loops of claudins varies 








Figure 3. Diagram of Claudin-1. The amino acid composition of the two extracellular loops of 
claudin varies significantly among other claudins, resulting in a wide range of isoelectric 
points (Schneeberger and Lynch, 2004). 
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It has been shown, using recombination methods, that there are portions of the ZO-1 and 
ZO-2 scaffolding proteins that allow for the independent determination of whether and where 
claudins are polymerized in the tight junction (Umeda et al., 2006). This relationship suggests 
that the tight junction is actually a complex of various proteins that are interacting with one 
another to form the barrier between the apical side and basal side of the epithelium. Another 
interaction in the tight junction sealing-strands are between rows of claudin and occludin 
transmembrane adhesion proteins embedded in the plasma membrane of two interacting cells. It 
has been hypothesized that the extracellular domains of claudin and occludin bind the proteins to 
one another and the intracellular termini interact with the scaffolding proteins that link the tight 
junction to actin (Alberts et al., 2008).  
These interactions among tight junction proteins (i.e. claudin, occludin, ZO) can 
dynamically change in response to various extracellular stimuli (Shen et al., 2008). It has been 
demonstrated through fluorescence recovery after photobleaching and other methods that the 
majority of occludin diffuses rapidly within the tight junction. In contrast, the majority of 
claudin-1 is stabilized at the tight junction complex when compared to occludin, however, 
claudin-1 still is localized under different environmental conditions (Shen et al., 2008). Overall, 
the majority of tight junction associated ZO-1, occludin, claudin-1, and β-actin do not remain 
bound in a complex at steady state. This suggests that at various environmental conditions, the 
epithelial cells are able to adapt to their surroundings by changing the integrity of their tight 
junction to modify permeability and that mutational analysis of claudins reveal proteins in this 
family regulate ion flux.  
However, even though occludin is not required for basal barrier (i.e. ion flux) properties 
of epithelia as suggested by occludin knockout mice, phosphorylation of occludin has been 
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shown to play an important role in regulating barrier properties. For instance, changes in 
occludin phosphorylation states have been associated with increased endothelial permeability in 
response to vascular endothelial growth factor (Antonetti et al., 1999; Harhaj et al., 2006). There 
are also several other studies relating the site-specific occludin phosphorylation to occludin 
function.  
For example, T403 and T404 occludin phosphorylation enhance both the trafficking of 
the protein to the tight junction and paracellular barrier function (Suzuki et al., 2009). Whereas, 
phosphorylation of occludin sites Y398 and Y402 reduces occludin–ZO-1 interactions, interferes 
with occludin localization at the tight junction, and sensitizes monolayers to oxidant-induced 
barrier disruption (Elias et al., 2009). Similarly, phosphorylation of the more distal occludin 
S490 site, which is located within the C-terminal coiled-coil occludin/ELL  OCEL domain, 
attenuates the interaction between occludin and ZO-1 (Sundstrom et al., 2009) and is associated 
with occludin endocytosis and barrier loss in endothelial cells in response to vascular endothelial 
growth factor (Murakami et al., 2009). Another site on occludin that is phosphorylated is Ser408. 
CK2-mediated phosphorylation of occludin S408 controls the interactions between occludin, 
ZO-1, claudin-1, and claudin-2, and suggest S408 phosphorylation as a molecular switch that 
regulates tight junction structure and paracellular pore pathway flux. (Raleigh et al., 2011).  
 There has also been evidence that mutations in Ser471 on occludin can cause changes in 
the regulation of tight junction barrier properties. It has been shown that this specific site may 
enhance occludin:ZO-1 complex stability (Tash et al., 2012). To test this hypothesis, the serine 
residue at site 471 was replaced with aspartic acid (i.e. Ser471D) – a phosphomimetic mutation. 
The point mutated occludin was then transiently transfected into MDCK cells and upon 
observation using a confocal microscopy, the mutated occludin demonstrated good apical border 
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co-localization with ZO-1 (Tash et al., 2012). Also it was shown by using peptides with and 
without a phosphogroup on Ser471 that the capture of the PDZ3-SH3-GuK (PSG) domain, the 
point of interaction between occludin and ZO, of ZO-1 is inhibited more by the phosphogroup 
peptide than the peptide without a phosphogroup (Tash et al., 2012). These results suggest that 
the acidic head of the occludin coiled coil domain interacts with the GuK domain of PSG with 
high affinity and phosphorylation of Ser471 enhances occludin:ZO-1 complex stability (Tash et 
al., 2012). Collectively, these studies reveal that occludin acts in a phospho-dependent manner to 
regulate cellular processes associated with the tight junction complex. However, the role of 
Ser471 phosphorylation was incompletely understood. The location of this site within a ZO-1 




 To determine the role of Ser471 phosphorylation, stable cell lines expressing point 
mutants were created. Madine Darby Canine Kidney (MDCK) cells were selected as these 
readily form tight junctions and have been well-characterized in junctional properties. The cell 
lines created included; wild-type occludin (WTOcc) and in order to determine if phosphorylation 
of Ser471 contributes to barrier function, a phosphoinhibitory mutation was made by changing 
the wild type serine at occludin site 471 to alanine (i.e. Ser471A). Serine was changed to alanine 
because the latter amino acid lacks a hydroxyl group making the mutated occludin incapable of 
being phosphorylated at this site (Figure 4). This is known as a phosphoinhibitory mutation 
because the alanine does not bear a hydroxyl group on its side chain and therefore cannot be 
phosphorylated by kinases. In addition, a phosphomimetic mutation was made by replacing 
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serine at site 471 with a negatively charged aspartic acid (i.e. Ser471D). It was hypothesized that 
the state of phosphorylation at 471 would affect tight junction integrity and as a result change the 





The studies reveal that overexpressing Ser471AOcc significantly reduces transepithelial 
resistance when compared with WTOcc, whereas there was no significant drop in transepithelial 
resistance for the Ser471D line (Figure 6 and 7). Further, the barrier to TAMRA, a ~400 Da 
fluorescent molecule, was also dramatically reduced in the Ser471A expressing cells compared 
to WTOcc while Ser471D did not demonstrate any change (data not shown). In addition, 
immunocytochemistry reveal large breaks in tight junction strands in the Ser471A expressing 
 
Figure 4. Structure of the Amino Acids. Serine is the amino acid that is present in the WTOcc 
471 site. There are structural similarities between alanine and serine. The main difference is 
the presence of a methyl group (green) on alanine and lack of a phosphorylation site (i.e. 
phosphoinhibitory). Aspartic acid has a carboxyl group (blue) making the amino acid bear an 
overall negative charge just as a phosphate group making it a phosphomimetic. The hydroxyl 
groups in red do not perform in phosphorylation because they are involved in forming 
peptide bonds.  
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cell lines compared to WTOcc or Ser471D expressing cells (Figure 5).  These data suggest that 
the phosphosite at Ser471 may play a role in regulating formation or maintenance of tight 



















Figure 5. Tight Junction Proteins are Mislocalized in Occludin Ser471A Mutant Cell Lines. 
Immunocytochemical maximum projected stacks (3 μm thick) of indicated proteins using a 63x 
confocal objective with 5x zoom for tight junction proteins (image courtesy of Mark Bolinger). 
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Changes in electrical resistance could be due to small pores forming specific ion channels  
as observed for Ser408 phosphorylation of occludin (Turner et al., 2012) or may be due to large 
gaps in the junction complex leading to non-specific ion flux. The observed alterations in tight 
junction immunofluorescence microscopy suggested the latter but quantitative data of specific 
ion flux would provide critical data to support this model. The project was designed to identify if 
the decrease in transepithelial resistance in the Ser471A line was due to changes in specific ion 
flux or a generalized change in ion flux.  Therefore, an electrophysiological study of the MDCK 
occludin mutant cell lines was conducted. To set up this experiment, an Ussing chamber 
apparatus was utilized. This apparatus allows rapid control of the basal and apical environmental 
conditions by introducing various solutions. In this study, Ringer solution was initially used 
(Table 1) on both the apical and basal sides. Transepithelial resistance was measured by inducing 
a bipolar current of 20 µA. The diffusion transepithelial potential was measured by changing the 
solution on either the apical or basal side. By using the Goldman-Hodgkin-Katz and Kimizuka-
Koketsu equations, we were able to calculate the absolute permeability of the ions (i.e. sodium, 
potassium, and chloride). We hypothesize that since the Ser471A cell line had the lowest 
transepithelial resistance and improper tight junction formation, the Ser471A should have the 






   
 
Figure 6. Phosphoinhibitory (Ser471A) Lines are “Leaky” Compared to Ser471D or WT. 
Trans-epithelial electrical resistance 3 days post confluent (image courtesy of Mark 
Bolinger). 
Figure 7. Phosphoinhibitory (Ser471A) Lines are “Leaky” Compared to Ser471D or WTOcc. 
Trans-epithelial electrical resistance 4 days post confluent (image courtesy of Mark Bolinger). 
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Figure 8. Fusion-protein construct transfected into MDCK cells. The red dot represents the 
approximate site at which the mutation is made.  




Madine-Darby Canine Kidney (MDCK) cells were originally derived from the kidneys of 
a normal male cocker spaniel in 1958 (Cho et al., 1989). When these cells are grown on a porous 
membrane, they form a confluent monolayer with well-developed intercellular occludin 
junctions (Misfeldt et al., 1976; Cereijido et al., 1978). The original MDCK cells used in our 
experiments were obtained from ATTC. To transfect the plasmids with a plasmid (Figure 8) the 













To plate the MDCK cells/lines on the transwell, they were first trypsinized for 15 minutes 
and then counted on a hemocytometer.  130,000 cells were plated in each well with 300 μL 
MEM MDCK cell media and 500 μL media placed outside the transwell.  Cells were then 
monitored via microscope daily.  Confluence typically occurred around two days after plating, at 
which point experiments were carried out on the fourth day post confluence because it was noted 
through experience that this is the optimal time it took the MDCK cells to form a tight 
monolayer.  The media was changed daily between plating and the experiment to facilitate the 




All MDCK cells were cultured on Millicell-CM Biopore (EMD Millipore, Billerica, MA) 





 Hepes ringer solutions are buffered solutions made to mimic physiological conditions in 
the cell. The ringer solution that contains the full concentration composition will be abbreviated 
as HR, whereas the ringer solution with the concentration of the ion reduced will be referred to 
as XHR, where X will equal to the percent of the ion present from the original. For example 
when the sodium concentration was diluted by 75% compared to the original HR, the reference 
to this solution is 0.25[Na+]HR.  
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 The concentration of sodium was dropped by 75% so that a comparable difference 
between the HR on the apical on basal side versus inducing a concentration gradient when 
measuring voltage potential via the Ussing chamber. In order to balance the osmolarity of the 
solution when reducing the concentration of sodium in ringer solution, we added the appropriate 
amount of mannitol. This same procedure was followed in making the ringer solution for 
potassium ion. The ingredients for the solutions used (i.e. HR, 0.25[Na+]HR, and 0.25[K+]HR) is 
























Table 1. Ingredients of a Hepes Ringer (HR) Solution. The appropriate amount of 









































Table 2. Ingredients of a Hepes Ringer Solution with Diluted [K+]. The appropriate 
amount of mannitol was used to balance the osmolarity of the solution.  
Table 3. Ingredients of a Hepes Ringer Solution with Diluted [Na+]. The appropriate 
amount of mannitol was used to balance the osmolarity of the solution.  
 25 
Electrophysiology Methods and Calculations: 
 
Electrophysiological recordings were performed on epithelial monolayers in an Ussing 
chamber (Harvard Apparatus #U9926/T) (Figure 9). Voltage and current clamps were performed 
using the EC-800 epithelial amplifier (Warner Instruments) with Ag/AgCl electrodes and an 
Agarose bridge containing 3M KCl. The transepithelial resistance was measured under the 
‘Resistance’ mode by passing a constant bipolar current pulse (Io) of 20 µA through the 
epithelium and recording voltage deflection (Vo). Ohm’s law was used to calculate 
transepithelial resistance from Vo and Io. The series resistance was measured in absence of the 
epithelium and subtracted from the transpithelial resistance. Dilution potentials were measured 
under the ‘Current Clamp’ mode by clamping the transepithelial current to zero and recording 
the equilibrium voltage generated by NaCl diffusion. All experiments were conducted at 37o C. 
Electrical potentials obtained from blank inserts were subtracted from those obtained from 
inserts with epithelial monolayers as published in other literature (Hou et al., 2005). 
Transepithelial resistance of the confluent monolayer of cells was determined in Ringer solution 
(135 mM NaCl, 5 mM KCl, 10 mM HEPES, 10 mM glucose, 1.8 mM CaCl2, 1 mM MgCl2). 
Dilution potentials were measured when buffer B (33.75 mM NaCl, 5 mM KCl, 10 mM HEPES, 
10 mM glucose, 1.8 mM CaCl2, 1 mM MgCl2) or buffer C (135 mM NaCl, 1.25 mM KCl, 10 
mM HEPES, 10 mM glucose, 1.8 mM CaCl2, 1 mM MgCl2) replaced Ringer solution on the 











Figure 9. Diagram Detailing the Various Components of an Ussing chamber. In order to find 
out the permeability ratio the solution in either the apical side or basal side was changed to a 
different concentration of sodium. The reference was the basal side of the membrane 
(modified after Li et al., 2004). 
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The ion permeability ratio for the monolayer was calculated from the dilution potential 
using the Goldman-Hodgkin-Katz equation: 
 
η  =  – (ε – ev) / (1 – ε ev), 
 
where η is the ratio of permeability of the monolayer to Na+ over the permeability of to Cl– (η = 
PNa/PCl ); ε is the dilution factor (ε = Cbasal/Capical); v = eV/kT (V is the dilution potential, k is the 
Boltzmann constant, e is the elementary charge and T is the temperature in Kelvins). The 
condition we use this equation is only when we induce a concentration gradient by filling the 
apical and basal sides of the Ussing chamber with unsymmetrical solutions. Using the 
permeability ratio derived from using the Goldman-Hodgkin-Katz equation, the absolute 
permeabilities of sodium and chloride were calculated by using the simplified Kimizuka-Koketsu 
equation: 
 
PNa  =  (G / C)  *  (RT / F
2)  *  (η / (1 +  η)) 
PCl  =  (G / C)  *  (RT / F
2)  *  (1 / (1 +  η)), 
 
Where G is the total conductance of the membrane that can be measured by Ohm’s law (V = I*R 
or G = I/V), C is the concentration of ion in solution, R is the gas constant, F is the Faraday 
constant, and η is the ratio of permeability of the monolayer to Na+ over the permeability of to 
Cl–. The permeability of K+ was measured similarly to Na+ (with the chemical gradient of 5 mM 























  A one-way ANOVA with Bonferroni post-hoc test was used to determine whether or not 
there is a statistical difference in the permeability of sodium ions in the different Ser471 occludin 
mutants of MDCK. Normalization of each cell line to WTOcc was made because WTOcc had 
the overexpressed human occludin and so do Ser471A and Ser471D. By normalizing using 
WTOcc values, it will eliminate overexpression of human occludin as an extraneous factor. 























MDCK cells were grown to confluence on membrane filters and inserted into the Ussing 
chamber. Hepes ringer solution was applied to both sides and Ohm’s Law was used to calculate 
transepithelial resistance after application of bipolar current. The transepithelial resistance for the 
occludin Ser471A mutant cell line (28.9 ± 3.7 Ω*cm2) was significantly lower compared to that 
of the WTOcc (45 ± 15.8  Ω*cm2), Ser471D (44 ± 6.8  Ω*cm2), and parental cell lines (51  ± 13 
Ω*cm2) (P < 0.05) (Figure 10, Table 4). The transepithelial resistance of the Ser471D, however, 
was approximately the same as that of the WTOcc and parental. These relative values are 
consistent with earlier recordings using the ECIS real-time measurement of electrical resistance 
in which the Ser471A line had a lower recorded transepithelial resistance compared to that of the 
















Group Parental WTOcc Ser471A Ser471D 
TER 51  ± 13 Ω*cm2 45 ± 15.8  Ω*cm2 28.9 ±  3.7  Ω*cm2 44 ± 6.8  Ω*cm2 
Table 4. Transepithelial Resistance (TER) Values for all Cell Lines. The TER is lower in the 
Ser471A cell line compared to that of the others. Data expressed as Mean ± SD. 
Figure 10. Normalized Transepithelial Resistance for Each of the Cell Lines. Data expressed as 




 The permeability for the sodium, chloride, and potassium ions were calculated as well. 
When the MDCK monolayer was challenged with an apical-to-basal chemical gradient (135 mM 
NaCl at the apical side to 33.75 mM NaCl at the basal side), it was found that a positive 
diffusional potential (Figure 15) had developed across the monolayer (with the basal side as zero 
reference). This positive diffusional potential was consistent when the MDCK monolayer was 
challenged with an apical-to-basal chemical gradient using potassium ions instead. The trend was 
seen for all the MDCK cell lines without any significant differences among the groups. The 
experiment was also performed with a basal-to-apical chemical gradient and found that the 
direction of gradient had no effects on the measurements of diffusional potential. The Goldman-
Hodgkin-Katz equation calculated the ratio of permeability of sodium over chloride at 1.62 ± 0.3 
for the wild type cells compared to 1.35 ± 0.07 in cells expressing the Ser471A transgene (P < 
0.05). (Table 5, Figure 11). This suggests that either the PNa was lower or PCl was higher in this 
cell line. The equation was also used to calculate the ratio of permeability of potassium over 
chloride at 1.17 ± 0.06 for Ser471A cell line and 1.35 ± 0.11 for the wild type (P < 0.05) (Table 
5). After calculating the absolute permeability of the ions using the Kimizuka-Koketsu equation, 
it was found that the permeability for sodium, chloride, and potassium were significantly higher 
in the Ser471A MDCK cells compared to that of the WTOcc, Ser471D, and parental (P < 0.05, n 
= 12) (Table 5). There was a 28% increase in PNa, an increase of 24% in Pk, and an approximate 
54% increase in the PCl in the Ser471A line compared to WTOcc. Therefore, the decreased 
permeability ratio for both sodium over chloride and potassium over chloride in the Ser471A cell 









Figure 12. Absolute Permeability of Sodium for Each Cell Line (n=12). Data expressed as Mean 
± SD (n = 12). *P < 0.05 compared to parental, WTOcc, and Ser471D. 
Figure 11. Permeability Ratio for Sodium over Chloride. Data expressed as Mean ± SD (n = 

















Figure 14. Absolute Permeability of Potassium for Each Cell Line (n=12). Data expressed 
as Mean ± SD (n = 12). *P < 0.05 compared to parental, Ser471WT, and Ser471D. 
Figure 13. Absolute Permeability of Chloride for Each Cell Line (n=12). Data expressed as 


















Group Parental Ser471WT Ser471A Ser471D 
PNa/PCl 1.56 ± 0.16 1.62 ± 0.3 1.35 ± 0.07 1.48 ± 0.09 
PK/PCl 1.31 ± 0.08 1.29 ± 0.12 1.18 ± 0.06 1.25 ± 0.06 
PNa  (10-6 cm/s) 2.58 ± 0.58 3.13 ± 1 3.99 ± 0.45 2.84 ± 0.42 
PCl (10-6 cm/s) 1.53 ± 0.35 1.79 ± 0.58 2.75 ± 0.31 1.77 ± 0.26 
PK (10-6 cm/s) 2.01 ± 0.46 2.30 ± 0.75 3.23 ± 0.36 2.21 ± 0.33 
Table 5. Permeability Ratio and Absolute Permeability Data, (n= 12). Data expressed as Mean 




 Occludin is a hyperphosphorylated protein with a high degree of regulation in diverse 
cellular functions including barrier formation and regulation, cell migration, and division. Ser471 
phosphorylation has been shown to enhance interaction with ZO-1 (Tash et al., 2012) but the 
cellular consequence of this phosphorylation site was unknown. This study has shown that 
introducing a phosphoinhibitory mutation, Ser471A, caused tight junction formation to be 
compromised. Concurrent work done in our lab revealed through immunocytochemistry imaging 
that the Ser471A cell line had breaks in the tight junction (Figure 5). In addition, ECIS studies 
revealed that the transepithelial resistance of the MDCK cells significantly decreased when 
transfected with Ser471A (Figures 6 and 7). Therefore, it was hypothesized that the Ser471A 
MDCK cell line would have non-selective ion flux because of the incomplete tight junction 
formation and lowered transepithelial resistance.  
The quantitative results obtained using the Ussing chamber were consistent with the 
transepithelial resistance work done using the ECIS. In either set-up, the transepithelial 
resistance was significantly lower for the Ser471A cell line compared to the other three cell lines 
(i.e. parental, WTOcc, and Ser471D). This suggests that phosphorylation status of Ser471 plays 
an important role in determining tight junction integrity through perhaps interacting with ZO-1 to 
form a stable protein complex. By forming tighter junctions, occludin phosphorylated at Ser471 
allows for greater transepithelial resistance and lower permeability for ions. When comparing the 
Ussing chamber values with those of other electrophysiological studies utilizing the apparatus, it 
was observed that the transepithelial resistance for MDCK with occludin (Yu et al., 2005) was 
similar to the transepithelial resistance of WTOcc MDCK cell line used in our study. In order to 
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test, however, if the change in transepithelial resistance was due to a specific flux of ions, the 
Goldman-Hodgkin-Katz and Kimizuka-Koketsu equations were utilized.  
 Using the Goldman-Hodgkin-Katz equation, the permeability ratio for sodium over 
chloride was always greater than one, regardless of the cell line, suggesting that there is an 
overall greater permeability to sodium ions compared to chloride ions, which is consistent with 
previous studies (Yu et al., 2005; Yu et al, 2009; Figure 15). After calculating the absolute 
permeabilities for the sodium, potassium, and chloride ions using the Kimizuka-Koketsu 
equation, there was a significant increase in permeability for all ions in the Ser471A cell line 
suggesting nonspecific ion flux. On the contrary, by placing a phosphomimetic mutation (i.e. 
Ser471D), we saw that the absolute permeability for all ions were similar to that of the WTOcc 
cell line. This strengthens the claim that phosphorylated Ser471 is involved in maintaining the 
integrity of the tight junction and strengthening the barrier to ion flux.  
In addition, there was a decrease in the permeability ratio in the Ser471A cell line 
suggesting that there is a net increase in anion permeability compared to that of WTOcc. It has 
been shown that MDCK cells are cation selective with a relative permeability ratio, PNa/PCl, of 
1.7 (Misfeldt et al., 1976). This suggests that the absence of a phosphorylation site on Ser471A 
deregulates tight junction formation (i.e. disrupts tight junction integrity) allowing bigger anions, 
such as chloride, to cross the epithelium relatively easier. This effect may also be due to a steep 
charge gradient established by increasing the diffusion of the cations through gaps in the tight 
junction of the Ser471A cell line and therefore increasing the net positive charge on the apical 
side compared to the basal side. This increase in positive charge may be attracting more chloride 
ions (i.e. negative charge), which can now freely diffuse as well through the membrane due to 
poor tight junction formation in the Ser471A cell line, to the apical side resulting in the increased 
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permeability of the anion. This electrophysiological phenomenon was observed regardless of 
which side the charge gradient was set up (i.e. apical or basal). The permeability ratio for 
potassium over chloride ions followed the same trend as that described above for the sodium 
over chloride ions.  
Previous studies of tight junctions have established a close association between the 
scaffolding protein, ZO-1, and the transmembrane protein, occludin, and identified multiple 
phosphorylation sites as potential regulators of their interaction. It has also been shown in vivo 
that the occludin:ZO-1 interaction is modulated by phosphorylation events on specific sites 
(Balda et al., 1996; Elias et al., 2009; Kale et al., 2009; Raleigh et al., 2011; Rao et al., 2002). In 
occludin, four of these sites segregate structurally and possibly functionally – two adjacent to the 
primary interaction site (Ser471 and Y474) in the acidic head and two in the secondary interface 
(Ser490 and Ser508) on the basic face (Tash et al., 2012). Y474 phosphorylation is associated 
with binding p85 of phosphatidylinositol 3-kinase at the leading edge of migrating cells (Du et 
al., 2010) while Ser490 and Ser508 are associated with vascular permeability after VEGF 
treatment (Sundstrom et al., 2009) or HIV encephalitis (Yamamoto et al., 2008). Ser471, 
however, may have a role in in regulating ZO-1 binding. The CC peptide 468-475, containing 
Ser471, was shown to be more effective at blocking PSG and ZO-1 capture when phosphorylated 
at Ser471 (pSer471) (Tash et al., 2012). This suggests, along with data acquired in our study, that 
phosphorylation of occludin at Ser471 may regulate proper tight junction formation in vivo and 













Figure 15. Diagram illustrating Ionic Flux in Response to an Ussing Chamber Dilution. The 
positive dilution potential recorded when the apical side was being filled with 0.25[Na+]HR 
solution. The sodium ions responded to the newly formed gradient by freely diffusing to the 
apical side making the net charge on this side of the membrane more positive compared to 




Ongoing research by Mark Bolinger as part of his dissertation reveals that Ser471 of 
occludin may contribute to cell packing and assembly of the tight junctions. Cell lines expressing 
Ser471A proliferate normally but have reduced packing and tight junction formation. Cells 
normally stop proliferation through contact inhibition involving signaling from adherens 






Figure 16. Model of the Hippo Pathway in Mammals. After initial cell to cell contact, there is an 
intracellular cascade that triggers the phosphorylation of YAP/TAZ priming it for either 
inhibition or degradation. This allows for TEAD to transcribe mRNA responsible for cell 
proliferation and anti-apoptosis leading to the hypertrophic phase (Zhao et al., 2010).  
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When two cells come in contact with one another through various interactions, they form 
a stable connection. An example of this interaction is when two E-cadherin proteins on adjacent 
cells form a bond and bring two cells in contact with one another. The current research reveals 
that in MDCK epithelial monolayers, after this initial interaction, the cells experience a period of 
packing in which the cells proliferate without hypertrophic growth yielding smaller cells at high 
density followed by tight junction formation yielding densely packed and highly regular cells 
with tight junctions on all sides (Figure 17).  Research by Mark Bolinger revealed that Ser471A 
cells fail to pack and form tight junctions; this was consistent with the immunocytochemistry 
imaging done earlier that revealed breaks in the tight junction for Ser471A cell lines (Figure 5). 
An identical phenotype could be achieved with inhibition of cell cycle progression using 
roscovitin treatment after cell monolayers forms but before packing. Further, GRK4, 5, or 6 was 
identified as a kinase for Occ Ser471 and inhibitors of this kinase could also replicate the 
phenotype preventing or delaying packing and tight junction formation.  These data suggest that 
phosphorylation of occludin Ser471 does contribute to regulating tight junction formation and 
likely accounts for the nonspecific ion flux through the gaps in the tight junctions of the 
transgenic Ser471A MDCK cells. However, the effect of Ser471 phosphorylation appears much 
broader than directly affecting tight junction formation and contributes to control of cell packing 

























Figure 17. Diagram Detailing the Formation of Tight Junctions. It has been shown that the 
timely cell packing contributes to tight junction formation. Ser471A causes the barrier to not 
form properly by preventing cell packing and directly impacting tight junction formation 




One drawback of the study was that we did not account for liquid junction potential 
across agar bridge pipettes. The junction between the agar in the bridges and the apical or 
basolateral solution represents a static liquid junction. To account for this error, a 3M KCl was 
used in the bridges because this minimizes the liquid junction potential. Furthermore, in 
symmetrical solutions, the liquid junction potential of the apical and basolateral pipettes should 
cancel each other out. However, when asymmetrical solutions are used to measure diffusion 
potentials, which is the principal method used to determine relative permeability of ions, the 
liquid junction potential of the two pipettes differ and a significant error can be introduced.  
There are two major problems while attempting to predict the liquid junction potentials of 
3M KCl pipettes (Barry and Diamond, 1970). First, prolonged immersion of the 3M KCl pipettes 
in the bathing solution introduces the bathing solution (i.e. ringer solution) into the pipette tip, 
changing its composition so that the apparent liquid junction potential become dependent on the 
history of the pipette. Second, even with fresh 3M KCl, the empirically determined liquid 
junction potential differs from the theoretical value and is somewhat unpredictable (Yu et al., 
2009).  
In our setup, we tried correcting for this error by using a blank insert, a common 
approach used by many other investigators in this field. In order to calculate the proper 
transepithelial potential using this method, we would first measure the potential across the blank 
insert, VEF, and then subtract that value from the measured potential in the presence of the 




VM = VEM - VEF 
 
Where VEF = VL
b – VL
a (i.e. the difference in liquid junction potential between the two pipettes).  
 However, this experimental design is flawed. The above formula assumes that there is no 
potential across the blank filter. In fact, it has been observed that the blank filter has 0.4 µm 
pores and is most likely freely permeable to small ions so it must behave as a liquid junction 
potential. Therefore, the correct relationship between the measured potential and the pipette 




a) + VF 
 
where VF is the voltage of the filter, which is typically ignored in most studies.   
 In order to correct for this liquid junction potential in the future, we will use the 
generalized Henderson-Planck equation (Barry and Diamond, 1970): 
 







Sf  =  [∑(ziui)( ai
A –  ai
B)] / [∑( zi
2ui)( ai




where zi represents the charge of the ion, ai is the activity of the ion on either the apical (A) or 








Name z u 
Cl -1 1.0388 
K 1 1 
Na 1 0.682 
HEPES -1 0.3 
Ca 2 0.4048 









Another drawback of the study was the use of only two cations (i.e. sodium and 
potassium) and one anion (i.e. chloride). In order to further validate the non-selectivity of the 
Ser471A cell line, more cations and anions need to be tested using the same protocol described 
above (i.e. diluting the Hepes ringer solution and utilizing the Ussing Chamber, the Goldman-
Hodgkin-Katz, and Kimizuka-Koketsu equations to determine absolute ion permeability values) 









Table 6. Charge and mobility values used to calculate the liquid junction potential for 
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